Clinical Trial Update: Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erlotinib with radiotherapy in non-resectable locally advanced non-small cell lung cancer; status is UNKNOWN with no results reported y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN